Introduction {#s1}
============

In 1990 Trichopoulos \[[@pmed-0050193-b001]\] suggested that prenatal exposure to high levels of pregnancy oestrogens might affect the risk of breast cancer. This hypothesis, which has since evolved to include other in utero hormonal and biological factors \[[@pmed-0050193-b002]\], sparked a considerable amount of research on the prenatal origins of breast cancer, relying mainly on birth size measures as indirect markers of the in utero environment. Published estimates of the strength of the association between birth size and breast cancer, however, have been far from consistent \[[@pmed-0050193-b003]--[@pmed-0050193-b033]\], and several unanswered questions remain, including uncertainty regarding the magnitude and shape of the association as well as the extent to which it may be mediated, confounded, and/or modified by known breast cancer risk factors.

We set up a collaborative group to bring together and re-analyse the original individual participant data from published and unpublished studies on pre- and perinatal factors and subsequent risk of breast cancer. This paper reports on the birth size--breast cancer association. This re-analysis provides several scientific advantages over previously published overviews \[[@pmed-0050193-b034]--[@pmed-0050193-b036]\]. First, it is large and comprehensive, comprising published and unpublished information on over 22,000 breast cancer cases from 32 studies, many of which have been enlarged since their original publications. Second, the availability of primary data from each individual participant provided a unique opportunity to estimate study-specific effects using similar definitions and adjustments across studies. Third, it allowed a detailed investigation of between-study heterogeneity and its possible sources. Fourth, study-specific data could be combined, if appropriate, to produce far more precise estimates of the association of birth size with breast cancer risk than those obtained from any single study.

Methods {#s2}
=======

Identification of Studies and Data Extraction {#s2a}
---------------------------------------------

We attempted to identify studies that collected information on at least one measure of birth size and were based on incident breast cancer cases. Studies were identified by computer-assisted searches (including PubMed and Embase) up to the end of June 2007, manual searches of reference lists, personal communication with investigators, and publicity regarding our collaboration in international conferences. The search strategy used the term "breast cancer" in combination with "birth weight," "birth size," "birth length," "head circumference," "ponderal index \[PI\]," and "gestational age" (details of search strategy available on request). A total of 27 published and seven unpublished cohort and case-control studies \[[@pmed-0050193-b003]--[@pmed-0050193-b033]\] were identified, including two twin studies \[[@pmed-0050193-b010],[@pmed-0050193-b011]\] and a cohort of premature or very low birth weight babies \[[@pmed-0050193-b009],[@pmed-0050193-b021]\]. One study \[[@pmed-0050193-b032]\] was excluded because most of its participants contributed to a larger unpublished study (Swedish Young Female Breast Cancer \[SYFBC\], [Table S1](#pmed-0050193-st001){ref-type="supplementary-material"}) and another \[[@pmed-0050193-b033]\] because its original individual participant data could not be retrieved. The included studies refer to independent study populations, with the exception of two (Seattle Breast Cancer in Young Women \[BCYW\] \[[@pmed-0050193-b004]\] and Seattle Perinatal Factors and Breast Cancer \[PFBC\] \[[@pmed-0050193-b007]\], [Table S1](#pmed-0050193-st001){ref-type="supplementary-material"}) that were conducted in the same population but used different sources of birth size information. Data from the smallest one (Seattle PFBC; 442 cases and 393 non-cases) were excluded from the analyses whenever appropriate (as indicated in [Figures 1](#pmed-0050193-g001){ref-type="fig"}, [2](#pmed-0050193-g002){ref-type="fig"}, [S1](#pmed-0050193-sg001){ref-type="supplementary-material"}, and [S2](#pmed-0050193-sg002){ref-type="supplementary-material"}). Each participating study had previously obtained all relevant ethics approvals; only nonidentifiable data were sent to the London School of Hygiene & Tropical Medicine (LSHTM).
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Data on individual participants were obtained in a standardised format. They included measures of birth size (i.e., weight, length, and head circumference) and, if available, data on potential confounding factors, mediators, and effect modifiers ([Tables 1](#pmed-0050193-t001){ref-type="table"}, [S1](#pmed-0050193-st001){ref-type="supplementary-material"}--[S3](#pmed-0050193-st003){ref-type="supplementary-material"}). These individual-level data were centrally collated and crosschecked at LSHTM, with data quality queries clarified by the principal investigators. As the birth size distributions were very different in the twin studies \[[@pmed-0050193-b010],[@pmed-0050193-b011]\] and in the cohort study of premature/low birth weight babies \[[@pmed-0050193-b009],[@pmed-0050193-b021]\] ([Tables S4](#pmed-0050193-st004){ref-type="supplementary-material"}--[S6](#pmed-0050193-st006){ref-type="supplementary-material"}), these were examined separately. Analyses were restricted to singletons in the remaining studies and will hereafter be referred to as singleton studies. Participants were further excluded from all studies if they had a known history of cancer other than nonmelanoma skin cancer at entry into the study (i.e., at recruitment/start of follow-up), and if all birth size data were missing. For the two Nurses Health Studies \[[@pmed-0050193-b031]\], only nested case-control data were provided for the pooled analyses. Because of these exclusions and updated follow-up/recruitment in some studies \[[@pmed-0050193-b022],[@pmed-0050193-b023],[@pmed-0050193-b027],[@pmed-0050193-b031]\], study sizes may differ from those reported in the original study-specific publications.

###### 

Summary Characteristics of the 32 Participating Studies

![](pmed.0050193.t001)

Statistical Methods {#s2b}
-------------------

The primary exposure of interest was birth size as measured by weight (kg), length (cm), head circumference (cm), and PI (defined as weight \[kg\]/height \[m\]^3^) at birth. These measures were examined as quantitative (for increments of approximately one standard deviation \[SD\], i.e., 0.5 kg for weight, 2 cm for length, 1.5 cm for head circumference, and 2.5 kg/m^3^ for PI) and as categorical variables. In the analyses of singleton studies, birth weight was categorised according to commonly used categories (\<2.500, 2.500--2.999, 3.000--3.499 \[baseline\], 3.500--3.999, and ≥4.000 kg); for four studies \[[@pmed-0050193-b029]--[@pmed-0050193-b031]\] birth weight data were only available as predefined categories equivalent to these except in one study \[[@pmed-0050193-b030]\] in which the three middle categories were collapsed into a single one ([Table S4](#pmed-0050193-st004){ref-type="supplementary-material"}). Categories for birth length, head circumference, and PI were defined by quartiles of their overall distributions among all participants in cohort studies and non-cases in case-control studies. Study-specific quartiles for birth weight, length, and PI (no data were available for head circumference) were similarly generated in each twin study \[[@pmed-0050193-b010],[@pmed-0050193-b011]\] and in the cohort of premature/low birth weight babies \[[@pmed-0050193-b021]\].

Assessment of birth size--breast cancer associations was performed primarily using a two-stage approach \[[@pmed-0050193-b037],[@pmed-0050193-b038]\]. Study-specific effects were first estimated and, if appropriate, pooled using a random effects model under the assumption that individual studies estimate different exposure effects because of potential heterogeneities in populations and data quality, but with the interest focused on their mean value. These pooled effects will hereafter be referred to as "two-stage," with the standard errors calculated from the inverse of the sum of the adjusted weights \[[@pmed-0050193-b038]\]. Study-specific effects were estimated as rate ratios in cohort studies and odds ratios in case-control studies (hereafter referred to as relative risks \[RRs\]) using models appropriate for each study design (i.e., Cox proportional hazard or Poisson regression for cohort studies; conditional logistic regression for nested \[all based on risk-set sampling\] and individually matched case-control studies; and logistic regression for frequency-matched case-control studies) \[[@pmed-0050193-b039]\].

The analytical time scale for cohort studies was age, with the beginning of the follow-up defined as the age at recruitment into the study or the age when outcome ascertainment became possible (e.g., through linkage to cancer registries). Follow-up ended at the age of breast cancer diagnosis, death, emigration, or last follow-up, whichever occurred earlier. RRs for cohort studies were thus adjusted for age at diagnosis. The proportional hazards assumption was checked in Cox models graphically, by comparing stratum-specific cumulative incidence curves before fitting the models, and formally via the test of proportionality based on Schoenfeld residuals \[[@pmed-0050193-b040]\]. In Poisson models the assumption of time-constant effects (i.e., proportionality) was assessed by testing the significance of interactions between birth size measures and age. RRs for cohort studies were additionally adjusted for calendar year by stratification. The matching variables specified for each case-control study (e.g., year of birth, calendar period, recruitment centre, area of residence, or ethnicity) were accounted for in the estimation of RRs either through matched analyses (for individually matched studies) or adjustment (for frequency-matched studies). The RRs quoted in the text refer to these minimally adjusted RRs unless otherwise specified. The statistical significance of each birth size--breast cancer association, and of quadratic departures from the assumption of linearity of effects, were assessed within each study by likelihood ratio tests and for pooled estimates by Wald tests. Possible sources of between-study heterogeneity were investigated and formally tested using the Cochran Q statistic and the I^2^ quantity based on standard cut-off points \[[@pmed-0050193-b041],[@pmed-0050193-b042]\]. Two-stage pooled estimates of groups of RRs were only calculated if there was no statistically significant evidence of systematic heterogeneity. The influence of individual studies was assessed by sequentially dropping each one before pooling study-specific estimates.

To increase statistical precision, one-stage pooled analyses, in which overall pooled estimates are derived from a single model, were also conducted on the subset of cohort studies of singleton women with birth records information. Random effects multivariable Cox regression (frailty) models \[[@pmed-0050193-b043]\], which account for within study clustering, were fitted to assess exposure-response relationships for each birth size variable and to estimate their joint associations with breast cancer risk. These models were also used to estimate the breast cancer cumulative incidence curve corresponding to the baseline birth length category (i.e., 49.0--49.9 cm). Cumulative incidence curves for the other birth length categories were obtained by multiplying the baseline curve by the corresponding category-specific RRs. A similar approach was used to calculate cumulative incidence curves for the five birth weight categories (taking the 3.000--3.999 kg category as the baseline).

As the availability and classification of potential confounders varied from study to study, adjustment for confounding was performed separately for each variable, or group of variables, within each study and then pooled using the two-stage procedure. Consequently, the number of cases and non-cases involved in each analysis varied accordingly. To assess whether the birth size associations were modified by age, analyses were stratified by age at breast cancer diagnosis (\<45 y; 45--54 y, ≥55 y) for case-control studies and by a time-changing indicator of current age for cohort studies. Analyses were similarly stratified by menopausal status at diagnosis in the subset of studies with this information.

Two-stage and one-stage pooled analyses were repeated after excluding extreme birth size observations (i.e., values outside the singleton/twins/premature-specific means ± 4 SDs). Small study bias was assessed via the Egger funnel plot asymmetry test \[[@pmed-0050193-b044]\] and other forms of publication bias by meta-regression. All statistical analyses were performed in Stata \[[@pmed-0050193-b045]\]. All tests of significance are two-sided.

Results {#s3}
=======

Characteristics of the Study Participants {#s3a}
-----------------------------------------

A total of 32 studies contributed to these analyses, including 22,058 women with newly diagnosed invasive or in situ breast cancer and 604,854 non-cases. The characteristics of the participating studies are summarised in [Table 1](#pmed-0050193-t001){ref-type="table"} (further details in [Tables S1](#pmed-0050193-st001){ref-type="supplementary-material"}--[S3](#pmed-0050193-st003){ref-type="supplementary-material"}). Information on birth weight was based on birth records, parental recall when the women were 6--7 y old, mother\'s recall during the woman\'s adulthood, and on self-reports in adulthood. In analyses by source of birth weight data, the two last categories produced similar effect estimates and thus were combined into one single category of adult reports. Data on categorical birth weight were available for all 32 studies, whereas data on continuous birth weight and on other measures of birth size were available for a smaller number of studies ([Tables 1](#pmed-0050193-t001){ref-type="table"} and [S2](#pmed-0050193-st002){ref-type="supplementary-material"}).

Birth Size and Breast Cancer Risk {#s3b}
---------------------------------

Two-stage pooled analyses of RRs, stratified by source of birth size information, showed that the risk of breast cancer in singletons increased with increasing birth weight categories in studies based on birth records or on parental recalls in childhood (although significant only for the first, *p* for linear trend (*p*~t~) = 0.001), but not in those based on adult reports ([Figure 1](#pmed-0050193-g001){ref-type="fig"}; study-specific estimates available in [Table S4](#pmed-0050193-st004){ref-type="supplementary-material"}). Continuous analysis of birth weight (restricted to 25 studies; [Figure 2](#pmed-0050193-g002){ref-type="fig"}) revealed a similar pattern. A 0.5-kg increment (about one SD) in birth weight was associated with a statistically significant increase in risk in studies based on birth records (pooled RR = 1.06 \[95% confidence interval (CI) 1.02--1.09\]; *p* = 0.002) and a borderline significant increase in those based on parental recalls when the women were children, but not in studies based on adult reports, with statistical evidence of heterogeneity between birth weight data sources (*p* = 0.003). Categorical and continuous analyses of birth weight stratified by study design revealed a positive trend in risk with increasing birth weight categories in data from cohort, nested case-control, and individually matched case-control studies (albeit only statistically significantly for the latter), but not in data from frequency-matched case-control studies ([Figures S1](#pmed-0050193-sg001){ref-type="supplementary-material"} and [S2](#pmed-0050193-sg002){ref-type="supplementary-material"}). There was evidence of between study-design heterogeneity of the continuous birth weight effect (*p* = 0.03), but it was accounted for by differences in birth data sources when examined via meta-regression of the birth weight RRs on both study design and birth data sources (*p*-value for study-type heterogeneity = 0.67; for adult reports versus other sources = 0.08).

Data on birth length and head circumference were available, respectively, for 11 and nine singleton studies, all derived from birth records. Two-stage pooled analyses stratified by study design showed no statistical evidence of heterogeneity within or between strata in either categorical or continuous analyses ([Figures 3](#pmed-0050193-g003){ref-type="fig"}, [4](#pmed-0050193-g004){ref-type="fig"}, and [S4](#pmed-0050193-sg001){ref-type="supplementary-material"}; study-specific estimates available in [Tables S5](#pmed-0050193-st005){ref-type="supplementary-material"} and [S7](#pmed-0050193-st007){ref-type="supplementary-material"}) and, thus, overall pooled RRs were estimated. Breast cancer risk increased with increasing birth length (*p*~t~ = 0.004; [Figure 3](#pmed-0050193-g003){ref-type="fig"}), with women ≥ 51 cm long at birth having 17% (95% CI 2%--35%) higher risk of developing breast cancer relative to those in the baseline category. Women with a head circumference ≥35 cm had an 11% increase (95% CI −5% to 29%) in risk relative to those in the baseline category, whereas those with a head circumference \<33 cm had a 10% decrease (95% CI −30% to 15%) (*p*~t~ = 0.01) ([Figure 3](#pmed-0050193-g003){ref-type="fig"}). These estimates corresponded to pooled RRs of 1.06 (95% CI 1.03--1.10) per one SD (= 2 cm) increment in birth length ([Figure 4](#pmed-0050193-g004){ref-type="fig"}) and 1.09 (1.03--1.15) per one SD (= 1.5 cm) increment in head circumference ([Figure S4](#pmed-0050193-sg004){ref-type="supplementary-material"}). In contrast, there was no association with categorical ([Figure 3](#pmed-0050193-g003){ref-type="fig"}) or continuous PI (pooled RR per 2.5 kg/m^3^ increment = 1.01; 0.97--1.04; [Figure S3](#pmed-0050193-sg003){ref-type="supplementary-material"}; study-specific estimates available in [Table S6](#pmed-0050193-st006){ref-type="supplementary-material"}).
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The two twin case-control studies, both based on birth records, showed stronger associations of breast cancer risk with continuous birth weight (pooled RR per one SD increment = 1.57; 95% CI 1.20--2.07) and continuous birth length (1.23; 1.01--1.49) than those found among singleton studies, and a positive association with PI (1.36; 1.06--1.75) that was not observed in the latter ([Figure S5](#pmed-0050193-sg005){ref-type="supplementary-material"}). No association between any of these birth size measures and breast cancer risk was found in the cohort study of premature/low birth weight babies, which was also based on birth records ([Figure S5](#pmed-0050193-sg005){ref-type="supplementary-material"}; study-specific estimates available in [Tables S4](#pmed-0050193-st004){ref-type="supplementary-material"}--[S6](#pmed-0050193-st006){ref-type="supplementary-material"}).

Shape of the Birth Size--Breast Cancer Association in Singletons {#s3c}
----------------------------------------------------------------

In the subset of singletons in cohort studies based on birth records, all with continuous birth size data, the one-stage pooled dose-response plot for birth weight suggested a nonlinear (quadratic) relationship, with RR for women at the extremes of the distribution being slightly lower than predicted by the linear model. However, the test for deviation from linearity was not statistically significant (*p* = 0.20; [Figure S6](#pmed-0050193-sg006){ref-type="supplementary-material"}). The plots for birth length and head circumference were more consistent with a linear association (*p*-value for departure from linearity: 0.39 and 0.58, respectively; [Figure S6](#pmed-0050193-sg006){ref-type="supplementary-material"}).

Independence of Effects of the Various Birth Size Measures in Singletons {#s3d}
------------------------------------------------------------------------

Birth weight and birth length were strongly correlated with each other (*r* = 0.79, *p* \< 0.001, in the subset of cohorts with birth record data), and both were correlated with head circumference (*r* = 0.61 and *r* = 0.51, respectively; *p* \< 0.001 for both). Simultaneous one-stage pooled analysis of these three variables in the subset of cohort studies of singletons based on birth records showed that birth length was the measure with the strongest independent association with breast cancer risk ([Table 2](#pmed-0050193-t002){ref-type="table"}). The association with birth weight disappeared after adjustment for birth length and head circumference, while the association with birth length persisted, and remained of borderline significance, after adjustment for birth weight and head circumference.

###### 

Separate (Univariable) and Mutually Adjusted (Multivariable) Breast Cancer Incidence Rate Ratios for Continuous Weight, Length, and Head Circumference at Birth in Singletons

![](pmed.0050193.t002)

In this subset of cohort studies, all from developed countries, the cumulative incidence of breast cancer by age 80 y is estimated to be 10.0 per 100 singleton women in those who were shorter than 49 cm at birth and 10.0, 10.4, 11.5, respectively, per 100 singleton women who were 49.0--49.9, 50.0--50.9, and ≥51.0 cm at birth. Similarly, and as data on birth weight are more widely available, the cumulative incidence is estimated to change from 10.0 per 100 singleton women in those who weighed less than 2.500 kg at birth to 9.4, 10.4, 10.9, and 11.6, respectively, per 100 singleton women who weighed 2.500--2.999, 3.000--3.499, 3.500--3.999, and ≥4.000 kg at birth. About 45%--50% of women in these cohorts were ≥ 50 cm long, or ≥ 3.5 kg, at birth. If the observed effect estimates are valid, and assuming that birth size reflects some underlying process that is causally related to breast cancer, it is estimated that about 4.5%--5.0% of breast cancers by age 80 y in these study populations are attributable to length ≥ 50 cm, or weight ≥ 3.5 kg, at birth.

Consistency of the Findings {#s3e}
---------------------------

There was little evidence that the associations between the various birth size variables and breast cancer risk in singletons were confounded or modified by other peri- and postnatal factors in data from birth records ([Figures 5](#pmed-0050193-g005){ref-type="fig"} and [6](#pmed-0050193-g006){ref-type="fig"}), or adult reports ([Figure S7](#pmed-0050193-sg007){ref-type="supplementary-material"}). Even variables that were significantly associated with birth size, such as maternal height and maternal parity (e.g., correlation coefficients with birth length: *r* = 0.24 and *r* = 0.07, respectively; *p* \< 0.001 for both), woman\'s adult height (*r* = 0.29, *p* \< 0.001) and parental and woman\'s adulthood measures of socioeconomic status (SES) (*p* \< 0.01 and *p* \< 0.05, respectively), did not explain the positive association with breast cancer risk. In particular, adjustment for maternal height or the woman\'s adult height attenuated only slightly the effects of birth weight and length ([Figures 5](#pmed-0050193-g005){ref-type="fig"} and [6](#pmed-0050193-g006){ref-type="fig"}). Similarly, adjustment for the woman\'s adult body mass index (BMI) did not affect the birth size effects ([Figures 5](#pmed-0050193-g005){ref-type="fig"} and [6](#pmed-0050193-g006){ref-type="fig"}). Neither continuous gestational age (pooled RR per 1 wk increment = 0.99; 95% CI 0.96--1.03) or being preterm (unpublished data) was associated with breast cancer risk. Few studies collected data on the woman\'s use of oral contraceptives (OC) or hormone replacement therapy (HRT) ([Table S3](#pmed-0050193-st003){ref-type="supplementary-material"}), but their findings indicate that the birth size--breast cancer associations reported here are unlikely to have been confounded by ever use of these exogenous hormones (minimally adjusted and OC-adjusted pooled RRs per 2 cm increment in birth length: 1.14 (95% CI 0.82--1.61) and 1.14 (0.82--1.61), respectively; similarly, minimally adjusted and HRT-adjusted pooled RRs: 1.08 (0.92--1.25) and 1.07 (0.86--1.34), respectively).
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The effect of categorical ([Figure S8](#pmed-0050193-sg008){ref-type="supplementary-material"}; study-specific estimates available in [Table S8](#pmed-0050193-st008){ref-type="supplementary-material"}) or continuous birth weight ([Figure 7](#pmed-0050193-g007){ref-type="fig"}) was not modified by age (defined as current age for cohort studies and age at diagnosis for case-control studies). There was also no evidence of any interaction between age and continuous birth length, PI, or head circumference ([Figure 7](#pmed-0050193-g007){ref-type="fig"}). Menopausal status was known for 33% of the cases, but analysis restricted to the subset of studies with this information showed no difference in the birth size effects between pre- and postmenopausal women.

![Minimally Adjusted Pooled Breast Cancer RRs in Relation to Continuous Weight, Length, PI, and Head Circumference at Birth Stratified by Age (Restricted to Singleton Studies Based on Birth Records)](pmed.0050193.g007){#pmed-0050193-g007}

Sensitivity analysis showed that none of the categorical or continuous pooled birth size associations reported here was dominated by any single study. The association of birth size with breast cancer risk in birth record data persisted after exclusion of 1,510 in situ tumours among the case-control studies and censoring 28 diagnoses of in situ tumours in cohort studies (6% of all cases). Birth cohort (defined by the median year of birth in each study) and geographical area (North America, Western Europe, Eastern Europe, and Asia) did not explain any further between-study heterogeneity beyond that accounted for by source of birth size data.

The findings did not appear to be affected by study size bias (Egger funnel plot asymmetry test: *p* = 0.20). There was no statistical evidence of publication bias among the studies included in these analyses ([Table S9](#pmed-0050193-st009){ref-type="supplementary-material"}).

Discussion {#s4}
==========

We analysed individual participant data on over 22,000 women with breast cancer from 32 epidemiological studies of the association between birth size and breast cancer. This pooled analysis provided evidence of moderate positive trends in the risk of breast cancer among studies based on birth records, with risk increasing with increasing birth weight, length, and head circumference. Source of birth size data was identified as the main source of between-study heterogeneity, with positive associations of birth size with breast cancer risk found only in data from birth records and, to a lesser extent, in data from parental recalls when the women were aged 6--7 y, but not in data from self-reports or maternal recalls when the women were adults.

Simultaneous adjustment for weight, length and head circumference at birth showed that length, perhaps as a measure of linear growth, was the strongest predictor of risk despite the fact that the latter tends to be more poorly measured than weight or head circumference \[[@pmed-0050193-b046],[@pmed-0050193-b047]\]. Such finding should not however be overinterpreted because of the strong collinearities among these variables.

The birth size effect did not appear to be confounded or modified by known breast cancer risk factors. In particular, and contrary to previous reports \[[@pmed-0050193-b018],[@pmed-0050193-b023],[@pmed-0050193-b031]\], there was no evidence that the birth size effect was stronger for premenopausal breast cancer. The association between birth size and breast cancer risk was observed consistently in women born over a period of several decades, and in different geographical areas.

Strengths and Limitations {#s4a}
-------------------------

Because of its large size this pooled analysis provided greater statistical power than any of the contributing individual studies and, therefore, more precise estimates than those previously published. It was also possible to standardise the way in which the exposure and confounding variables were defined and coded, the choice of which variables to control for, and the type of analysis conducted, thereby removing these potential sources of heterogeneity across studies. The possible influence of bias needs to be considered. Publication bias is a general problem for pooled analyses. Because inclusion in this pooled analysis was not dependent on publication, this re-analysis is likely to have been less affected by publication bias than meta-analyses of the published literature. The two nonparticipating studies \[[@pmed-0050193-b032],[@pmed-0050193-b033]\] showed no association between birth weight and breast cancer, but they were based on small numbers of cases (12 and 74, respectively). We found no evidence of publication bias when examining the effect of study size, or year and type of publication.

Bias within studies, such as information or selection bias, might also have influenced the results. Exposure measurement error could have been a problem as we found evidence of statistical heterogeneity of effects by source of birth size data. Reports of birth weight by the participants themselves in adulthood, or by their mothers when the participants were adults, are likely to be more prone to measurement error than those based on birth records or on parental recall when the participants were children. This remark is consistent with the clear digit preference patterns found in the birth weight data reported by the women themselves, or their parents, but not in those from birth records (unpublished data). These errors are, however, likely to be mainly nondifferential and so likely to impose an attenuating bias in univariable analyses that use these sources of data as exposure measurements. Although differential misclassification is possible in studies in which exposure information was collected after diagnosis, it is unlikely that participants would have been aware of a possible link of birth size with breast cancer risk. Thus, the variability in results across the various sources of birth weight data might simply reflect different degrees of attenuation of the true birth weight effect due to different levels of random exposure misclassification. Selection bias could have been a problem, particularly in case-control studies. Although all case-control studies in this re-analysis were population-based, selection bias might still have occurred in studies with relatively low participation. We did not find evidence that studies with low participation levels provided systematically discrepant results (*p* for heterogeneity = 0.88). Bias due to incomplete follow-up is unlikely because all cohorts had high degrees of completeness.

Finally, the impact of potential confounding factors was evaluated by comparing effect estimates unadjusted and adjusted for single or multiple potential confounders. The results showed little variation. The availability of information on many potential confounding variables is a major strength of our pooled analysis. One drawback is that information for many of them was restricted to a few studies and therefore we could only assess the impact of each potential confounder separately, or only of groups with few of them at a time, when pooling data. Moreover, some of these factors were probably measured with some error. Thus, we cannot exclude residual or unmeasured confounding by these or other factors.

Biological Plausibility and New Perspectives {#s4b}
--------------------------------------------

These results provide no direct evidence about possible mechanisms underlying the birth size--breast cancer association. Trichopoulos\'s initial assumption \[[@pmed-0050193-b001]\] was that birth size was a correlate of foetal oestrogen exposure. Oestriol represents 90% of the oestrogens produced during pregnancy \[[@pmed-0050193-b048]\]. Birth size indicators have been found to be correlated with maternal oestriol levels \[[@pmed-0050193-b049]\] but, not with foetal levels \[[@pmed-0050193-b050]\]. Maternal and/or foetal levels of other growth factors, such as insulin-like growth factors \[[@pmed-0050193-b051],[@pmed-0050193-b052]\], leptin and adiponectin \[[@pmed-0050193-b053]--[@pmed-0050193-b055]\], and alpha-phetoprotein \[[@pmed-0050193-b056]\] have also been reported to be associated with birth size. The maternal and/or foetal hormonal environment associated with large birth size may alter programming of the breast, making it more susceptible to cancer initiation by endogenous hormone levels and other carcinogens later in life \[[@pmed-0050193-b057]\]. This altered programming may involve epigenetic changes in the expression of genes linked to cell proliferation, survival, and differentiation; these changes are likely to occur in the foetal mammary stem cells that give rise to all mammary epithelial structures and/or in cells that influence stem cell self-renewal and fate \[[@pmed-0050193-b058]\]. If pregnancy hormones are the real exposure of interest the use of a surrogate measure, such as birth size, may lead to considerable exposure misclassification with likely attenuation of the true effect. A moderate correlation of birth size with pregnancy hormone levels of about *r* = 0.35, as found with maternal oestriol \[[@pmed-0050193-b049],[@pmed-0050193-b059]\], implies that the observed RR of 1.06 per one SD increment in birth weight would correspond to a RR as large as 1.17 for one SD increase in the underlying true exposure (although the corresponding 95% CI would be wider). If, however, the in utero origins of breast cancer result from a complex interplay of several hormonal and nonhormonal processes \[[@pmed-0050193-b060]\], birth size may, in fact, be a better cumulative summary measure of all relevant exposures than measured levels of any single hormone.

Foetal growth is a predictor of a woman\'s growth and development during childhood and early adult life, and both age at menarche and adult height \[[@pmed-0050193-b061]\] are associated with breast cancer risk. Thus, the observed association between foetal growth and breast cancer may be partly mediated through postnatal growth. This pathway would be consistent with our finding of a stronger association of breast cancer with birth length than birth weight, as birth length for gestational age has been shown to be a stronger predictor of adult height than birth weight for gestational age \[[@pmed-0050193-b062],[@pmed-0050193-b063]\]. However the magnitude of the birth size effect was only slightly reduced after adjustment for adulthood height (but on the basis of a small number of cases, [Figures 5](#pmed-0050193-g005){ref-type="fig"} and [6](#pmed-0050193-g006){ref-type="fig"}), suggesting that the effect of birth size on risk may be only partly mediated through childhood growth \[[@pmed-0050193-b022],[@pmed-0050193-b023]\]. Similarly, the woman\'s BMI in adulthood did not confound the birth size--breast cancer associations. This was true even at premenopausal ages when adult BMI was inversely associated with breast cancer risk and thus any potential confounding by this variable would have lead to an underestimation of the true birth size effects.

Conclusions {#s4c}
-----------

This pooled analysis of individual participant data provides a comprehensive and detailed description of the association between birth size and breast cancer risk. Its findings are consistent with positive associations at both pre- and postmenopausal ages, and are largely independent of postnatal risk factors including adult body size. This study is an important addition to previous meta-analyses of published results \[[@pmed-0050193-b034]--[@pmed-0050193-b036]\] as it offers a comprehensive assessment of possible sources of between-study heterogeneity, and it clarifies the role of several potential confounders, mediators, and effect modifiers. The magnitude of the observed effect, although modest, is similar to those reported for other more established breast cancer risk factors. The RR per one SD increment in birth length of 9% is of similar magnitude to that associated with one SD increase in adult height in our data, and similar to an increase of about 7% for each additional 10 g of alcohol consumed on a daily basis \[[@pmed-0050193-b064]\]. Assuming causality, we estimated that about 5% of all breast cancers in developed countries could be attributable to high birth size (length ≥ 50 cm or weight ≥ 3.5 kg). The prevalence of high birth weight has been increasing in many countries \[[@pmed-0050193-b065],[@pmed-0050193-b066]\], consequent to rises in maternal prepregnancy BMI and maternal weight gain during pregnancy \[[@pmed-0050193-b067]--[@pmed-0050193-b069]\], but as this increase appears to reflect mainly rises in PI rather than birth length \[[@pmed-0050193-b070]\] it may not necessarily translate into an increase in the population attributable fraction. Even if real, the positive association of birth size with breast cancer would have to be interpreted in the context of U-shaped inverse associations of birth size with all-cause mortality \[[@pmed-0050193-b071]\], particularly mortality from circulatory diseases \[[@pmed-0050193-b071]\]. Nevertheless, continued investigation of the pathways through which prenatal factors may affect breast cancer risk, and the extent to which their effects may be mediated or modified by later life risk factors, may identify new targets for prevention of this disease in the future.
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